Casandra
Casandra Test Code QD96349Version 1 (DRAFT)
Performing Lab
Benzodiazepine, Confirmation, Urine
Clinical Use
Order TestUse
Confirmation testing for benzodiazepines in urine following a presumptive positive screen. Detects and quantifies specific benzodiazepine metabolites, aiding in definitive identification and clinical interpretation of benzodiazepine exposure.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
6 targets
AlprazolamFlurazepam MetaboliteLorazepamNordiazepamOxazepamTemazepam
Result Turnaround Time
3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
10 mL preferred, 5 mL minimum
Minimum Volume
5 mL
Container
Plastic leak‑proof urine container
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 72 hours |
| Refrigerated | 14 days |
| Frozen | 1 year |
Related Tests
Other tests from different labs that may be relevant
Benzodiazepine Confirmation, Urine
Mayo Clinic Lab
Benzodiazepines, Urine, Quantitative
ARUP Laboratories
Benzodiazepines Confirmation, Random, Urine
Mayo Clinic Lab
Benzodiazepines, Urine Screen with Reflex to Quantitation
ARUP Laboratories
Benzodiazepine and Metabolite Confirmation (Labcorp MedWatch®)
Labcorp
Benzodiazepines Confirmation, Chain of Custody, Random, Urine
Mayo Clinic Lab
Benzodiazepines, Screen and Confirmation, Urine (Pain Management)
Labcorp
Targeted Benzodiazepine Screen, Random, Urine
Mayo Clinic Lab
Lorazepam Confirmation, Quantitative, Urine
Labcorp
Designer Benzodiazepines, Screen With Confirmation, Urine Clinical
Labcorp